Meiragtx is a biopharmaceutical company that develops and commercializes gene therapy products to treat patients with inherited disorders.
Business Model:
Revenue: $42.3M
Employees: 201-500
Address: 450 East 29th Street
City: New York
State: NY
Zip: 10016
Country: US
Meiragtx is a biopharmaceutical company that develops and commercializes gene therapy products to treat patients with inherited disorders.
Contact Phone:
+16464902965
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/7/2018
IPO Valuation:
$407M
Ticker Symbol:
MGTX
IPO Price:
$15/share
Amount Raised:
$75M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2018 | Series B | 1 | $5M |
Essex Bio-Technology Essex Bio-Technology Essex Bio-Technology Essex Bio-Technology |
12/2017 | Venture Round | 2 | $2.7M |
UCL Technology Fund AlbionVC UCL Technology Fund AlbionVC |
2/2019 | Private Placement | $80M | 8/2019 | Post-IPO Equity | $75.2M | 11/2020 | Post-IPO Equity | $64.3M | 8/2022 | Post-IPO Debt | 1 | $75M |
Perceptive Advisors Perceptive Advisors |
6/2018 | IPO | $92M |
|
1/2017 | Grant | - | 1/2017 | Grant | - |
Target ALS Target ALS |
---|
Announced Date | Name | Price |
---|---|---|
10/2018 | Vector Neurosciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|